Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market Outlook

The global veterinary infectious disease diagnostics market is estimated to reach a valuation of US$ 1.9 billion in 2023. As per Future Market Insights (FMI) analysis, the veterinary infectious disease diagnostics market size is expected to surpass US$ 4.9 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 10.1% CAGR.

Global Trends & Scopes Transforming the Veterinary Infectious Disease Diagnostics Market

With diagnostic innovation, key players are devoted to providing a better experience for customers. Veterinarians may reliably obtain full diagnostic insights anytime, anywhere, thanks to artificial intelligence (AI) algorithms that provide cost-effective access to expert-level results, remote veterinary specialist evaluation, and post-diagnostic consultations.

Their unique product and service combination provides a full picture, allowing veterinarians to make faster, more educated medical decisions for more tailored treatment. They see their veterinarian clients as partners in their goal. As a result, they are keen to customize their services to the demands of the end user, tailoring their solutions to fit inside – and improve – their existing protocols.

The veterinary microbiology solutions given by key companies are designed with veterinary labs in mind and comprise a full variety of high-quality culture mediums, identification, and susceptibility testing items. It also has automated Johne's Disease instruments and reagents.

They collaborate with veterinarians, farmers, and pet owners regularly to create safe, effective, and practical solutions that improve treatment adherence. They cover the bulk of therapeutic segments and care for practically all species treated by veterinary medicine, including thousands of pharmacological, biological, nutritional, and diagnostic items.

Their multinational presence enables them to address concerns that are specific to each country. They accomplish this by offering products and services that satisfy the demands of all people who care for animals all around the world daily.

Key players are exploring novel solutions for more responsible reproduction management that respects the animal's well-being of companion animals, as well as food-producing animals.

Most of the diagnostics given by significant providers are ISO 17025 certified, including testing on PCR and ELISA platforms. Their comprehensive offerings provide industry-leading knowledge to end users. This comprises high-quality, low-cost diagnostic and surveillance testing options, as well as quick response times, frequently within 24 hours. Their diagnostic solutions and services meet the demands of the end-user and guarantee that they receive the data they require to reduce risks and protect the health and safety of their pet.

For reliable pathogen and bacterial testing in molecular laboratories, standardization and automation are required. Automated processing improves repeatability, reduces human error, and produces reliable results.

As a result, prominent players' integrated systems employ pathogen and viral load assays. These strategies aid in increasing efficiency and optimizing processes. Furthermore, their leading automated systems provide the flexibility and scalability required by labs to react to changing testing demands.

A Contrast with the Historical Market Scenario

According to a Future Market Insights analysis, the global market for veterinary infectious disease diagnostics has lately expanded dramatically. Top competitors in the industry are collaborating to fulfill increased demand for veterinary infectious disease diagnostics. The estimated CAGR, which was 11.9% from 2017 to 2022, is expected to fall to 10.1%.

Over the last few years, there has been a rapid surge in pet adoption, especially across developed and developing countries like the USA France, China, Germany, India, etc. This is acting as a catalyst for the growth of the veterinary infectious disease diagnostics market, and the trend is likely to follow during the forecast period.

Similarly, rising concerns regarding the spread of infectious diseases from animals to humans are providing an impetus to the growth of the veterinary infectious disease diagnostic market. According to the Centers for Disease Control and Prevention (CDC), scientists have estimated that around more than 6 out of every 10 known infectious diseases in people can be spread by animals.

Sales of rapid diagnostic tests for infectious diseases are mostly rising across developed countries due to increasing pet adoption and the flourishing animal healthcare market. However, demand for veterinary diagnostics is expected to grow at a substantial pace in emerging economies during the forecast period, owing to the increasing pet adoption, favorable government support, and increasing farm animal population.

Subsequently, the rapid expansion of veterinary hospitals and veterinary clinics, coupled with an increase in the number of veterinary practitioners and animal diseases diagnostic laboratories, is likely to further boost the growth of the veterinary infectious disease diagnostics market during the forthcoming years.

The expansion of the infectious animal diseases market size and burgeoning demand for veterinary diagnostics may create lucrative opportunities-leading market players in the future.

Category-wise Insights

Which is the Leading Segment in Veterinary Infectious Disease Diagnostics Market Based on Technology?

Sales of immunodiagnostics remain high in the global veterinary infectious disease diagnostics market.

Based on technology, the immunodiagnostics segment leads the global veterinary infectious disease diagnostics market in 2022 and is forecast to grow at a robust CAGR over the assessment period. Growing end-user preference for immunodiagnostics technology due to its various advantages is a key factor triggering the growth of this segment.

The increasing prevalence of animal diseases, coupled with rising immunodiagnostics sales, is anticipated to provide lucrative opportunities for market players during the forecast period.

What Animal Type Segment Holds Maximum Growth Potential in the Global Veterinary Infectious Disease Diagnostics Market?

Demand for Veterinary Infectious Disease Diagnostics Remains High in Companion Animal Category

Based on animal type, the companion animal segment is likely to grow at a relatively higher CAGR over the forecast period, owing to the rising pet adoption across developed and developing regions, increasing penetration of pet insurance, and increasing need for early detection and treatment of animal disease to eliminate the risk of disease spread.

Moreover, the expansion of markets like the pet care market and companion animals vaccines market is also favoring the growth of this segment.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Leading Key End User Segment in the Veterinary Infectious Disease Diagnostic Market?

Reference Laboratories to Remain Ideal Destinations for Veterinary Infectious Disease Diagnostics

Based on end users, the veterinary reference laboratories segment accounts for the leading revenue share in the global veterinary infectious disease diagnostics market. This is attributable to the increase in the number of veterinary practitioners, growing pet adoption rates, and the rapid expansion of the veterinary reference laboratory market.

Increased Adoption of Companion Animals fueling Growth Prospects

On a global basis, an increase in the total number of companion animals and their rate of adoption has been noted. Numerous studies have found links between pet ownership and good health, including the normalization of blood pressure, fewer cardiac arrhythmias, increased psychological stabilization, reduced anxiety, and enhanced well-being.

The demand for pet care goods and services is anticipated to rise in response to the rising pet population, which is likely to in turn fuel the expansion of related sectors, such as the veterinary infectious disease diagnostics market globally.

For example, in North America, a pet was owned by 68% of US homes or around 84.9 million families, as per the American Pet Products Association's (APPA) National Pet Owners Survey (2020–2021). Also, 43 million families had cats, 64 million had dogs, and 1.7 billion had all three. Thus, with such skyrocketing demand for pets, the need for veterinary infectious diseases diagnostics is expected to be growing rapidly too.

What Factors are Restraining the Growth of the Veterinary Infectious Disease Diagnostics Market?

Despite its optimistic stance, the global veterinary infectious diseases diagnostics market is facing various obstacles that are challenging its growth. Some of these obstacles are the increasing cost of veterinary treatment, poor availability of advanced veterinary disease diagnostic laboratories across low economies, and lack of pet insurance policies in some regions.

Region-Wise Overview

From Sample To Decision: Key Players offer Solutions based on Manual or Automated Technologies

The veterinary infectious disease diagnostics market is dominated by the United States, which accounts for 9.8% of total North American sales. The veterinary infectious disease diagnostics market in the United States is expected to reach a peak of US$ 1.7 billion.

The region's veterinary healthcare expenditure has increased significantly, which is likely to fuel market growth. Furthermore, the availability of healthcare programs and an increase in the number of efforts to enhance animal health are elements that are expected to increase the region's growth potential.

The purpose of veterinary diagnostics in the United States is to create ways to battle animal infections and zoonoses, while also helping the sensible use of antibiotics in veterinary medicine. Time-to-diagnosis and treatment accuracy are critical components of case management, as are infection control, the battle against multi-drug resistance, and the reduction of animal healthcare expenditures.

Key players provide a full variety of animal health solutions based on manual or automated technologies, from sample to decision. Market participants provide a diverse range of ELISA and RIA kits for veterinary diagnostics. Their principal products include salivary diagnostics, as well as assays for viral illnesses, autoimmunity, biogenic amines, and tumor markers.

They work to enhance the health and comfort of dogs suffering from neurologic illness. This is accomplished by combining the art of compassionate care with the science of veterinary neurology.

The relevance of animal health bioanalysis is recognized by key players. Key players are happy to support the creative work being done, from improving therapeutic capacities for precious pets to ensuring the food they ingest is safe.

With innovative solutions in pet diagnostics in the country, pet owners can be certain that their analytic requirements are met with the utmost care and attention.

Key Players in the United Kingdom Reinvest their Revenue for Research & Development Activities

The United Kingdom is a substantial veterinary infectious disease diagnostics market, with an expected value of US$ 206.2 million and a revenue growth rate of 9.1% during the forecast period. Key stakeholders in helping pet owners hope to better educate them by providing a variety of materials. These enable pet owners to make educated decisions about their pet's health. Moreover, their website is meant to be an intriguing and educational veterinary health reference.

The research and development operations of key players in the United Kingdom guarantee that their products represent cutting-edge RT-PCR and ELISA technology. Furthermore, they guarantee that the goods enable them to constantly launch fresh, inventive experiments.

To stay ahead of the curve in infectious disease diagnostics, they reinvest 30% of their revenue in research and development initiatives, collaborate with premier experts and reference laboratories throughout the world, and engage in European research programs.

The primary focus of research centers is to provide creative solutions, tests, samples, and so on for veterinary needs. For instance, the University of Glasgow's Veterinary Diagnostic Services department is dedicated to processing all data clearly and transparently, as well as securely keeping and disposing of all data following GDPR rules.

On request, they can provide complimentary swabs, viral transfer medium, submission forms, and prepaid postal labels. In addition, laboratory findings are confirmed by veterinary consultants before being communicated to the submitting veterinarian practice.

In Japan, Key Players are Concentrating on Bacterial & Parasite Illnesses, such as ‘Zoonosis’

Japan accounts for 9.4% of overall revenues in the veterinary infectious disease diagnostics market. The Japanese veterinary infectious disease diagnostics market is worth US$ 351.6 million. This is attributed to the increasing acceptability of companion animals. Additionally, there is a significant need for animal proteins in the country, which is projected to drive regional market expansion.

Key players in Japan concentrate on a wide spectrum of bacterial and parasite illnesses of domestic animals, including zoonosis. Moreover, biosensor technologies are being tested for use in determining the health condition of individual animals.

Key players in Japan are providing diagnostic services employing new technology to diagnose novel illnesses, especially exotic diseases, to enhance animal health. This is done in response to requests from Japan's national and municipal governments.

Australian Market Players have Discovered the Market Gap for Natural Plant-derived Animal Medicines

Australia is a very profitable veterinary infectious disease diagnostics market, with a revenue growth rate of 8.1% and a projected value of US$ 174.1 million during the projection year. Key players and research institutions in the country are investigating methods to improve the welfare of pets and livestock. They accomplish this by establishing scientific tools for analyzing how animals' feelings are affected by standard management practices.

Key players in the country supply animals with complicated illnesses with inexpensive, world-class medical, surgical, and emergency care. For instance, one market participant collaborates with both pet owners and veterinarians to give treatment at vet clinics around Greater Sydney via their mobile service. They claim to collaborate with veterinarians to give the best possible care for the owner's pet.

Many animal problems are detected, diagnosed, and solved by Australian market players in collaboration with veterinarians and animal health officials. Furthermore, they collaborate with primary farmers and industry to find creative solutions to issues. Certain key players, for instance, have employed a 3D scanner to get an accurate image of a horse's Laminitis-affected hoof. They then successfully tailored a 3D-printed shoe to support and heal the hoof.

With an aging pet population and accompanying age-related disorders, there are few novel and natural therapies to assist in giving treatment for problems like osteoarthritis. As a result, important manufacturers discovered a market gap for natural plant-derived animal medicines that are both safe and effective. This is done largely to promote greater health and well-being for companion animals, with a concentration on cannabis-derived chemicals.

New Entrants are Catching Up with Key Players: Start-Up Economy

Start-up companies are offering veterinary solutions that are incorporated with artificial intelligence (AI), which is contributing to the global veterinary infectious disease diagnostics market growth:

• Biotech Laboratories - It is a company that creates veterinary diagnostic devices for infectious illnesses. RapidSTATUS and LabSTATUS reagents and accessories are available for Lyme disease, anaplasmosis, ehrlichiosis, leptospirosis, babesiosis, leishmania, and other infectious disorders.
• Trecento Diagnostics - It creates testing products based on molecular assays for human and veterinary pet care diagnostics. The firm creates tools to identify and monitor infection, infectious illnesses, and autoimmune disorders, with Lyme disease being a particular ailment that is conveyed to people and animals by infected ticks. When doing DNA extraction for its tests, the business uses pee instead of blood for regular testing. The firm offers a non-invasive fast test for detecting Lyme disease that detects the Lyme antigen, Borrelia burgdorferi, in a patient's urine sample. The organization offers to test companion animals to evaluate the animal's health and welfare.
• Biogal - It offers innovative treatment goods and services for animal health. Patented bio-therapeutic treatments for infectious disorders in pets and animals. The company provides products such as Parvoguard, a patented feed supplement for puppies that protects against canine parvoviral; SmartEasy, an AI-based device with an integrated app that aids in data retrieval; and point-of-care diagnostics kits for animal diseases, such as Pen-side kits for animal disease diagnosis.
• CisGEN - It offers innovative treatment goods and services for animal health. Patented bio-therapeutic treatments for infectious disorders in pets and animals. The company provides products such as Parvoguard, a patented feed supplement for puppies that protects against canine parvoviral; SmartEasy, an AI-based device with an integrated app that aids in data retrieval; and point-of-care diagnostics kits for animal diseases, such as Pen-side kits for animal disease diagnosis.

Key Companies Revamping the Veterinary Infectious Disease Diagnostics Market Space

Due to the presence of multiple established competitors, the veterinary infectious disease diagnostics market share is very competitive. To capitalize on market growth potential, these firms are focusing on increasing their reach through acquisitions, expansions, product approvals, and launches.

Recent Developments:

• In July 2018, Zoetis Inc. announced the completion of its acquisition of Abaxis, a manufacturer and developer of diagnostic devices for veterinary point-of-care use.
• In November 2021, with the acquisition of DMV Imaging, FUJIFILM Europe hopes to extend its veterinary diagnostic client offering with products and services. DMV Imaging, based in Lyon, France, has specialized in providing veterinary point-of-care laboratory diagnostics.
• In March 2021, TRUFORMA was formally launched into commercialization by Zomedica Corp., a veterinary health firm that manufactures point-of-care diagnostics devices for cats and dogs.
• In September 2021, Heska Corporation purchased a controlling ownership in Biotech Laboratories U.S.A. LLC, which is a pioneer in fast assay diagnostics testing. Biotech Laboratories U.S.A. LLC strives to make animals healthy by delivering high-quality diagnostic solutions to veterinarians, livestock producers, and pet owners across the world.

KEY MARKET PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET

• Zoetis Inc.
• Thermo Fisher Scientific
• Virbac
• Biomerieux SA
• Heska Corporation
• IDvet
• NEOGEN Corporation
• QIAGEN N.V.
• Randox Laboratories Ltd.

Key Segments Profiled in the Veterinary Infectious Disease DiagnosticsMarket Survey

By Technology:

• Immunodiagnostics
• Molecular Diagnostic
• Others

By Animal Type:

• Companion Animal
• Food-producing Animals

By End User:

• Reference Laboratories
• Veterinary Hospitals & Clinics
• Point-of-Care
• Research Institutes & Universities

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe